ABN AMRO Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-36,180
Closed -$12.6M 233
2025
Q4
$12.6M Sell
36,180
-348
-1% -$118K 0.12% 88
2025
Q3
$11.7M Buy
36,528
+448
+1% +$139K 0.12% 88
2025
Q2
$14.1M Buy
36,080
+563
+2% +$226K 0.18% 60
2025
Q1
$15.4M Sell
35,517
-3,975
-10% -$1.6M 0.21% 59
2024
Q4
$14.4M Buy
39,492
+294
+0.8% +$123K 0.19% 58
2024
Q3
$20.2M Buy
39,198
+64
+0.2% +$34.2K 0.28% 50
2024
Q2
$21.4M Sell
39,134
-763
-2% -$403K 0.32% 46
2024
Q1
$20.7M Sell
39,897
-767
-2% -$381K 0.31% 48
2023
Q4
$19.3M Sell
40,664
-3,572
-8% -$1.65M 0.32% 45
2023
Q3
$19.2M Buy
44,236
+638
+1% +$289K 0.35% 42
2023
Q2
$19.5M Sell
43,598
-3,152
-7% -$1.45M 0.4% 36
2023
Q1
$21.5M Buy
+46,750
New +$22.2M 0.48% 33

Other funds holding ELV

ABN AMRO Bank's ELV Position: Q1 2026 in Review

ABN AMRO Bank sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 36,180 shares — an estimated $12.6M sold.

ABN AMRO Bank first reported a position in ELV in Q1 2023 and held it in 12 quarters. The position peaked at $21.5M in Q1 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • ABN AMRO Bank reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • ABN AMRO Bank sold 36,180 Elevance Health shares in Q1 2026, an estimated $12.6M.
  • ABN AMRO Bank first reported a position in Elevance Health in Q1 2023 and held it in 12 quarters.
  • ABN AMRO Bank's Elevance Health position peaked at $21.5M in Q1 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on ABN AMRO Bank's 13F filing for Q1 2026, filed 22 Apr 2026.